Medical Research
-
Green Bananas and Resistant Starch: What Two Research Findings Show
The humble green banana has been hiding in plain sight. For years, it was the fruit you passed over, the one left…
-
New Study Links Very Low Testosterone to Higher Risk of Cancer Death
For years, doctors have told men that low testosterone is bad for their sex drive, their energy, their mood. Now comes word…
-
Brain Changes Precede Alzheimer’s Plaques by Years, and Memory Awareness Fades Before Dementia
The clock on dementia starts ticking long before the first forgotten name. New research confirms what many in the longevity field have…
-
Study Finds Cancers Hiding from T Cells May Be More Vulnerable to Immune Attack
For years, the logic seemed airtight. Cancer cells that stripped away a key molecular flag — MHC class I — were considered…
-
Rural Counties Cut Cancer Deaths Far Less Than Big Cities Since 1991, Studies Show
The gap in cancer survival between urban and rural America is not just a statistic — it carries real, measurable consequences for…
-
Lymphoma Research Foundation Awards 24 New Research Grants
NEW YORK, June 17 — The Lymphoma Research Foundation, the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and…
-
Montreal Researchers Find SLAMF6, an Internal T Cell Brake That Works Without Tumor Input
MONTREAL — The immune system has a self-destruct switch. Cancer cells have learned to flip it. And for years, doctors have been…
-
Johann Lafer Says Lymphoma Cannot Be Cured After Early Chemotherapy Gains Shrank His Lymph Nodes
Understanding Lafer’s Condition Lafer was diagnosed with an indolent, low-grade, non-Hodgkin lymphoma earlier this year, with the diagnosis being made public in…
-
Montreal researchers identify molecular mechanism that sabotages cancer immunotherapy
MONTREAL — For a significant number of cancer patients, the most advanced immunotherapies simply stop working. Tumors that initially shrink eventually grow…
-
Columbia and Tübingen Researchers Find Protein NFIL3 Drives CAR T-Cell Exhaustion
Engineered immune cells known as CAR‑T cells have revolutionized treatment for blood cancers, yet their impact on solid tumors such as breast,…
-
Cancer Cells Hiding From Killer T Cells Become Targets for Helper T Cells
For decades, the prevailing view in oncology held that cancer cells that lose MHC class I molecules become invisible to cytotoxic CD8⁺…
-
Study Reveals Hidden Tumors May Be More Vulnerable to Immune Attack
Michigan, June 6, 2026 — cybernewschronicle.com — Cancer cells that go invisible to the immune system might have just painted a target…
-
Oral Arginine Cuts Amyloid Buildup in Fly and Mouse Models of Alzheimer’s
TOKYO, June 6, 2026 — infopulsetoday.com — Researchers in Japan have made a promising discovery in the fight against Alzheimer’s disease, reporting…
-
Scripps Research Finds STING Protein Fuels Alzheimer’s Inflammation
LA JOLLA, June 5 — A research team at Scripps Research has identified a specific biochemical alteration that drives chronic inflammation in…
-
Scientists Find Molecular Switch Locking Alzheimer’s Inflammation On
LA JOLLA, June 5 — Researchers at Scripps Research have made a significant discovery in understanding the molecular mechanism behind the chronic…
-
Scripps Team Finds Protein Switch Behind Alzheimer’s Brain Inflammation in Mice
A specific chemical alteration to a single protein may be the mechanism that sustains destructive brain inflammation in Alzheimer’s disease, according to…
-
Scientists Capture 3D View of T Cells Attacking Cancer
Geneva, 5 June – A team of researchers from the University of Geneva and the CHUV/UNIL collaboration has produced the first detailed…
-
Breakthrough Study Challenges Notion of Irreversible Paralysis and Nerve Damage
For many years the prevailing view held that once nerve pathways in the brain or spinal cord are cut, they cannot regenerate,…
-
Cancer Society Adds Blood Test to Colorectal Screening, but Only for Those Declining Other Tests
United States, May 27, 2026 — cyberinktimes.com — The American Cancer Society (ACS) announced on May 27, 2026, that the Guardant Health…
-
Dr. Barzilai Targets Aging as Key to Combating Multiple Diseases
NEW YORK, July 10 — Dr. Nir Barzilai, an Israeli-American geneticist, has spent decades researching aging as a target in biomedical research.…
-
Keytruda in Cancer Care: How Pembrolizumab Works and Which Side Effects to Watch
Patients receiving pembrolizumab, the immunotherapy drug sold as Keytruda, commonly report a range of side effects including fatigue, musculoskeletal pain, diarrhea, nausea,…
-
FDA Panel Rejects MDMA Therapy for PTSD Approval
A significant decision was made by a panel of the United States Food and Drug Administration on June 5, 2024, as they…
-
Fatty Liver Disease Gets a New Name as MASLD Replaces NAFLD in Global Liver Societies’ Consensus
Under a novel nomenclature agreed upon by three prominent global liver organizations, a prevalent liver ailment is set to undergo a significant…
-
Fatty liver disease: New classification and understanding as of June 2023
Fatty liver disease (FLD), a condition characterized by the buildup of excess fat in the liver, has been a subject of increasing…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992